Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis
Joseph Hinchey, … , William R. Jacobs Jr., Steven A. Porcelli
Joseph Hinchey, … , William R. Jacobs Jr., Steven A. Porcelli
Published August 1, 2007
Citation Information: J Clin Invest. 2007;117(8):2279-2288. https://doi.org/10.1172/JCI31947.
View: Text | PDF
Research Article Article has an altmetric score of 15

Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis

  • Text
  • PDF
Abstract

The inhibition of apoptosis of infected host cells is a well-known but poorly understood function of pathogenic mycobacteria. We show that inactivation of the secA2 gene in Mycobacterium tuberculosis, which encodes a component of a virulence-associated protein secretion system, enhanced the apoptosis of infected macrophages by diminishing secretion of mycobacterial superoxide dismutase. Deletion of secA2 markedly increased priming of antigen-specific CD8+ T cells in vivo, and vaccination of mice and guinea pigs with a secA2 mutant significantly increased resistance to M. tuberculosis challenge compared with standard M. bovis bacille Calmette-Guérin vaccination. Our results define a mechanism for a key immune evasion strategy of M. tuberculosis and provide what we believe to be a novel approach for improving mycobacterial vaccines.

Authors

Joseph Hinchey, Sunhee Lee, Bo Y. Jeon, Randall J. Basaraba, Manjunatha M. Venkataswamy, Bing Chen, John Chan, Miriam Braunstein, Ian M. Orme, Steven C. Derrick, Sheldon L. Morris, William R. Jacobs Jr., Steven A. Porcelli

×

Figure 5

Protective immunity against virulent M. tuberculosis challenge in guinea pigs following vaccination with ΔsecA2.

Options: View larger image (or click on image) Download as PowerPoint
Protective immunity against virulent M. tuberculosis challenge in guinea...
(A) Outbred Hartley guinea pigs were vaccinated intradermally with saline, BCG, or ΔsecA2 (n = 5 animals per group) and challenged by aerosol 2 months later with 10–30 CFU of virulent M. tuberculosis H37Rv. Graphs show SEM of CFU of M. tuberculosis in lung, spleen, and mediastinal lymph nodes at 1 and 2 months after challenge for naive (white bars), BCG-vaccinated (gray bars), or ΔsecA2-vaccinated (black bars) animals (CFU counts obtained from a minimum of 3 and in most instances 5 animals; an exception was 2-month spleen CFU for BCG-vaccinated animals, in which counts were obtained from only 1 animal for technical reasons). (B) Quantitative scoring of histopathology graphed as the SEM of the rank scores for the groups of guinea pigs vaccinated and challenged as described in A. Images show representative low-power (×25) views of H&E-stained sections of mediastinal lymph nodes harvested from each group at 1 or 2 months after challenge. Scale bars: 1 mm. *P < 0.05, **P < 0.01, †P < 0.001 compared with unvaccinated group or between bracketed groups; 1-way ANOVA with Tukey’s post-hoc test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Referenced in 8 patents
Highlighted by 1 platforms
192 readers on Mendeley
1 readers on CiteULike
See more details